论文部分内容阅读
目的:探讨卡孕栓联合催产素预防剖宫产产后出血的临床效果。方法:选择2014年1月至2014年6月在我院住院并经阴道分娩的产妇92例,随机分为观察组和对照组各46例。对照组在胎儿娩出后给予催产素治疗,观察组在胎儿娩出后给予卡孕栓联合催产素治疗,比较两组产妇产后2h、24h出血量、第三产程持续时间、不良反应发生情况。结果:观察组产妇产后2h、24h出血量均少于对照组,第三产程时间短于对照组,差异有统计学意义(P<0.05);两组均无严重不良反应发生。结论:卡孕栓联合催产素预防剖宫产产后出血,能明显减少产后出血量,较好预防术后出血,且用药方便、安全、不良反应少。
Objective: To investigate the clinical effect of carbamazepine combined with oxytocin in preventing bleeding after cesarean section. Methods: Ninety-two cases of maternal hospitalized and vaginally delivered in our hospital from January 2014 to June 2014 were randomly divided into observation group and control group with 46 cases each. The control group was treated with oxytocin after the fetus was delivered. The observation group was treated with carboplatin and oxytocin after the fetus was delivered. The bleeding volume, the duration of the third stage of labor and the adverse reactions of the two groups were compared between the two groups. Results: The bleeding volume of the observation group was less than that of the control group at 2h and 24h postpartum, and the duration of the third stage of labor was shorter than that of the control group. The difference was statistically significant (P <0.05). No serious adverse reactions occurred in both groups. CONCLUSION: The combination of carbamazepine and oxytocin prevents bleeding after cesarean section, significantly reduces the amount of postpartum hemorrhage, and prevents postoperative bleeding. It is convenient, safe and has few adverse reactions.